Recommendations for Pfizer-BioNTech and Moderna Children’s COVID-19 Vaccines

During this COCA Call, presenters will discuss CDC’s new guidance on the pediatric COVID-19 vaccine primary series for children ages 6 months through 4 years old for Pfizer-BioNTech and ages 6 months through 5 years old for Moderna, including children who are moderately or severely immunocompromised.

This video can also be viewed at
https://emergency.cdc.gov/coca/wmv/2022/062222_video.mp4